<PAGE>
EXHIBIT 23.2
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the reference to our firm under the captions "Selected
Consolidated Financial Data" and "Experts" and to the use of our report dated
April 21, 2000 in Amendment No. 3 to Registration Statement on Form S-1
(No. 333-45588) and related Prospectus of Specialty Laboratories, Inc. for the
registration of 5,750,000 shares of its common stock.
Our audits also included the financial statement schedule of Specialty
Laboratories, Inc. listed in Item 16. This schedule is the responsibility of the
Company's management. Our responsibility is to express an opinion based on our
audits. In our opinion, the financial statement schedule referred to above, when
considered in relation to the basic financial statements taken as a whole,
presents fairly in all material respects the information set forth therein.
/s/ Ernst & Young LLP
Woodland Hills, California
October 17, 2000
